𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pregnancy and lactation after breast-conserving therapy for early stage breast cancer

✍ Scribed by Susan Higgins; Bruce G. Haffty

Publisher
John Wiley and Sons
Year
1994
Tongue
English
Weight
537 KB
Volume
73
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Breast-conserving therapy (BCT) for earl
Breast-conserving therapy (BCT) for early-stage breast cancer
✍ Rashmi K. Benda; Nancy Price Mendenhall; D. Scott Lind; Juan C. Cendan; Barbara πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 188 KB

## Abstract Several patient and tumor factors go into the decision process to determine whether a breast cancer patient is a good candidate for breast‐conserving therapy. The patient must be seen by all disciplines before any therapeutic intervention. When used appropriately, breast‐conserving ther

Predicting the rate and extent of locore
Predicting the rate and extent of locoregional failure after breast conservation therapy for early breast cancer
✍ Anne T. Stotter; Marsha D. McNeese; Frederick C. Ames; Mary J. Oswald; Nancy A. πŸ“‚ Article πŸ“… 1989 πŸ› John Wiley and Sons 🌐 English βš– 974 KB

Five hundred thirty-six cases of early breast cancer (T0 to T2, N0 to N1) treated with breast conservation therapy were monitored for a median interval of 64 months. Fifty-five locoregional failures occurred after a median interval of 40 months; the actuarial failure rate was 9% at 5 years and 19% a

Local recurrence after breast conservati
Local recurrence after breast conservation therapy for early stage breast carcinoma : Detection, treatment, and outcome in 266 patients
✍ Adri C. Voogd; Geertjan van Tienhoven; Hans L. Peterse; Mariad A. Crommelin; Emi πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 102 KB πŸ‘ 2 views

## Background: Controversy exists concerning the roles of mammography and physical examination in the detection of local recurrence after conservation therapy for breast carcinoma. in addition, the prognostic factors for and optimal treatment of patients with local recurrence are uncertain. ## Met

Breast-conserving therapy for Stage I-II
Breast-conserving therapy for Stage I-II synchronous bilateral breast carcinoma
✍ Smitha V. Gollamudi; Rebecca S. Gelman; Gloria Peiro; Lindsey J. Schneider; Stua πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 99 KB πŸ‘ 2 views

up for surviving patients was 95 months (range, 68-157 months). Pathology slides were available for review in 19 cases. Cosmetic results and complications after 1 Joint Center for Radiation Therapy and Depart-BCT were scored. Outcome was compared with that of 1314 patients with unilateral ment of Ra

Irradiation of the tumor bed alone after
Irradiation of the tumor bed alone after lumpectomy in selected patients with early-stage breast cancer treated with breast conserving therapy
✍ Vicini, Frank; Kini, Vijay R.; Chen, Peter; Horwitz, Eric; Gustafson, Gary; Beni πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 75 KB πŸ‘ 2 views

## Backgrounds and Objectives: We present the interim findings of our in-house protocol treating the tumor bed alone after lumpectomy with low-dose-rate (LDR) interstitial brachytherapy in selected patients with early-stage breast cancer treated with breast conserving therapy (BCT). Methods: From